Effects of SARAH Protocol in Women With Rheumatoid Arthritis
NCT ID: NCT05375422
Last Updated: 2022-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2022-02-07
2024-02-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SARAH Exercise Program in Patients With Rheumatoid Arthritis
NCT05727488
Progressive Resistance Exercise in Rheumatoid Arthritis
NCT02219022
Acute Effect of Resistance Training in Inflammatory Markers in Women With Rheumatoid Arthritis
NCT02401958
Effectiveness of Water Exercises on Isokinetic Muscle Strength
NCT01447264
Effectiveness of Technology-Supported Hand Strengthening and Stretching Exercises in Patients With Rheumatoid Arthritis
NCT04365842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SARAH group
The SARAH group will receive an exercise book containing 7 mobility exercises and 4 strength exercises that are performed using elastic materials that provide progressive degrees of resistance to movement. Patients will be guided in person by a trained professional, so that they are carried out without their presence, in the home environment, daily and monitored at periodically scheduled meetings. A total of 4 face-to-face meetings will be held during the 3-month follow-up. The SARAH group and the control group will receive information related to joint protection, use of splints, assistive devices and other general advice, as needed, will receive some booklets to reinforce the guidelines. The program will last 12 weeks, with 4 face-to-face meetings lasting 40 minutes and monitored in periodically scheduled meetings.
SARAH
Set of exercises with components of muscle strengthening, range of motion gain and home exercises.
Educational intervention
Information related to joint protection, use of splints, assistive devices and other general advice, as needed.
Control group
Control group will receive information related to joint protection, use of splints, assistive devices and other general advice, as needed, will receive some booklets to reinforce the guidelines.
After 12 weeks, the control group will also be invited to perform the SARAH protocol exercises.
Educational intervention
Information related to joint protection, use of splints, assistive devices and other general advice, as needed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SARAH
Set of exercises with components of muscle strengthening, range of motion gain and home exercises.
Educational intervention
Information related to joint protection, use of splints, assistive devices and other general advice, as needed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* using disease-modifying antirheumatic medication for at least 3 months
* over 18 years old
Exclusion Criteria
* diagnosis of another associated autoimmune disease
* having undergone previous surgical procedures on the hands
* having suffered a fracture in the joints of the upper limbs in the last six months
* being a patient on the waiting list for orthopedic surgery of the upper limb
* being pregnant.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Espirito Santo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samira Tatiyama Miyamoto, PhD
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samira Tatiyama Miyamoto, PhD
Vitória, Espírito Santo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUEspiritoSanto03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.